from Yahoo Finance https://ift.tt/2YXxVPV
-
LabCorp expands availability of at-home sample collection kit for COVID-19 testing
from Yahoo Finance https://ift.tt/2T1fHcN
-
U.S. FDA declines to review Bristol Myers, bluebird therapy for multiple myeloma
from Yahoo Finance https://ift.tt/2WUgWeC
The Latest
-
This mid-cap ASX tech share could be 30% higher in 12 months
-
Tuas terminates M1 acquisition
-
Guzman y Gomez exits US market, boosts Australia growth outlook
-
Which of these shares hitting 52-week lows can bounce back?